Caredx Inc (CDNA) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Caredx Inc   (NASDAQ: CDNA)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Caredx Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Caredx Inc's ROI in the third quarter of 2026?
Caredx Inc achieved a return on average invested assets (ROI) of 32.22 % in its third quarter of 2026, this is above CDNA's average return on investment of -33.29%.
Caredx Inc invested over the 12 months ending in its third quarter of 2026 $399 million

Despite the deterioration in its net income, company has improved ROI compared to the second quarter of 2026.

Within the Healthcare sector 39 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 837 to 2730.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 7.16 % -8.04 % -15.75 % -9.94 % -4.15 %
Y / Y Net Income Change TTM 111.69 % 129.12 % - - -
Investment (TTM) in Millions 502 439 332 323 333
Return On Investment (TTM) 32.22 % 31.1 % -2.45 % -6.05 % 16.31 %
CDNA's Overall Ranking # 2730 # 837 # 2111 # 416 #
Seq. Investment Change TTM 11.85 % 6.58 % -5.13 % -5.25 % -4.01 %
Seq. Net Income Change TTM 15.87 % - - - 25.41 %
Net Income (TTM) in Millions 129 111 -8 -21 61

CDNA Company Profile >> Back to CDNA Roi Comparisons >> See Annual CDNA Return On Investment



Return On Investment CDNA's Ranking
Within: No.
Industry # 4
Sector # 40
Overall # 2730

Return On Investment Statistics
High Average Low
29.42 %
-33.29 %
-163.04 %
(Jun 30 2026)   (Dec 31 2017)







Financial Statements
Caredx Inc's III. Quarter Investments $ 502 Millions CDNA's Balance sheet
Caredx Inc's III. Quarter Income $ 19 Millions Quarterly CDNA's Income Statement
CDNA's Income by Division See CDNA's Income by Division


CDNA Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 323 402 389 467 489
Y / Y Investment Growth -19.49 % 3.32 % -16.76 % -4.56 % 63.49 %
Net Income in Millions -21 53 -190 -77 -31
Y / Y Net Income Growth - - - - -
Annual Return On Investment -6.6 % 13.08 % -48.95 % -16.4 % -6.27 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CDNA's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CDNA's Competitors
Subscribers only: Roi for Caredx Inc's Suppliers
Subscribers only: Return On Investment for CDNA's Customers

Other Ratios
CDNA's Roa CDNA's Inventory Turnover Ratio CDNA's Growth Rates CDNA's Dividend Statistics
CDNA's Profitability Ratios CDNA's Asset Turnover Ratio CDNA's Dividend Growth
CDNA's Roe CDNA's Valuation Ratios CDNA's Financial Strength Ratios CDNA's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Exelixis Inc   75.01 %
Ironwood Pharmaceuticals inc   68.68 %
Rigel Pharmaceuticals Inc  68.50 %
Alnylam Pharmaceuticals Inc   63.14 %
Idexx Laboratories Inc  52.51 %
Aurinia Pharmaceuticals Inc   45.04 %
Nurix Therapeutics Inc   44.12 %
Medpace Holdings Inc   41.14 %
Rallybio Corporation  36.04 %
Eli Lilly And Company  32.00 %
Caredx Inc   30.65 %
Zevra Therapeutics Inc   29.88 %
Acadia Pharmaceuticals Inc   26.89 %
Standard Biotools Inc   23.91 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Intuitive Surgical Inc   16.30 %

Date modified: 2026-10-30T17:00:11+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.